Oura’s confidential IPO filing in May 2026, following its $11 billion Series E valuation in late 2025, anchors trader sentiment amid reports of a potential September listing targeting up to $3 billion in proceeds and a roughly $16 billion post-IPO market cap. Rapid revenue expansion—doubling toward $1 billion in 2025 and nearing $2 billion in 2026—supports premium multiples in the wearable-health sector, yet the spread across $10–20 billion+ brackets reflects uncertainty over final pricing, secondary share sales, and broader equity-market conditions. The 10.3 percent probability assigned to no IPO before January 2027 underscores sensitivity to SEC review timelines and macroeconomic factors.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$20B+ 15%
$15B–$17.5B 14%
$17.5B–$20B 14%
$10B–$12.5B 14%
$235,776 Vol.
$235,776 Vol.
<$7.5B
9%
$7.5B–$10B
9%
$10B–$12.5B
14%
$12.5B–$15B
11%
$15B–$17.5B
14%
$17.5B–$20B
14%
$20B+
15%
No IPO before January 2027
11%
$20B+ 15%
$15B–$17.5B 14%
$17.5B–$20B 14%
$10B–$12.5B 14%
$235,776 Vol.
$235,776 Vol.
<$7.5B
9%
$7.5B–$10B
9%
$10B–$12.5B
14%
$12.5B–$15B
11%
$15B–$17.5B
14%
$17.5B–$20B
14%
$20B+
15%
No IPO before January 2027
11%
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Market Opened: May 26, 2026, 12:28 PM ET
Resolver
0x69c47De9D...If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Resolver
0x69c47De9D...Oura’s confidential IPO filing in May 2026, following its $11 billion Series E valuation in late 2025, anchors trader sentiment amid reports of a potential September listing targeting up to $3 billion in proceeds and a roughly $16 billion post-IPO market cap. Rapid revenue expansion—doubling toward $1 billion in 2025 and nearing $2 billion in 2026—supports premium multiples in the wearable-health sector, yet the spread across $10–20 billion+ brackets reflects uncertainty over final pricing, secondary share sales, and broader equity-market conditions. The 10.3 percent probability assigned to no IPO before January 2027 underscores sensitivity to SEC review timelines and macroeconomic factors.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated


Beware of external links.
Beware of external links.
Frequently Asked Questions